Literature DB >> 10194066

Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways.

S C Gangloff1, N Hijiya, A Haziot, S M Goyert.   

Abstract

CD14, a protein expressed on the surface of monocytes and neutrophils, is a major receptor for lipopolysaccharide (LPS). Studies with normal and CD14-deficient macrophages show that responses to low concentrations of LPS require expression of CD14, whereas responses to high concentrations of LPS are CD14-independent. Since LPS isolated from different bacterial species shows structural variability, studies were performed to determine whether differences in LPS structure influence CD14-dependent and CD14-independent responses. Studies with LPS purified from Escherichia coli, Salmonella abortus subspecies equi, Salmonella minnesota, Pseudomonas aeruginosa, Neisseria meningitidis, Bacteroides fragilis, and Rhodobacter sphaeroides show that the strongest CD14-dependent responses require a typical O-antigen, long carbohydrate chains, at least 6 acyl chains in their lipid A, and 2-phosphorylated Kdo moieties; wild-type LPS lacking a typical O-antigen and containing short carbohydrate chains and 2-phosphorylated Kdo moieties induces the strongest CD14-independent response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194066     DOI: 10.1086/515176

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  23 in total

1.  Neisseria gonorrhoeae porin modifies the oxidative burst of human professional phagocytes.

Authors:  D R Lorenzen; D Günther; J Pandit; T Rudel; E Brandt; T F Meyer
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells.

Authors:  Lynn L Stoll; Gerene M Denning; Wei-Gen Li; James B Rice; Allan L Harrelson; Sara A Romig; Skuli T Gunnlaugsson; Francis J Miller; Neal L Weintraub
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

Review 3.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

Review 4.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

5.  Differential expression of CD14-dependent and independent pathways for chemokine induction regulates neutrophil trafficking in infection.

Authors:  Shalaka Metkar; Kwang Sik Kim; Jack Silver; Sanna M Goyert
Journal:  J Leukoc Biol       Date:  2012-05-16       Impact factor: 4.962

6.  Effect of lipopolysaccharides having different structures on the cardiovascular system of Wistar rats.

Authors:  I R Prokhorenko; G A Kustanova; E B Grazhdankin; D S Kabanov; A N Murashev; S V Prokhorenko; S V Grachev
Journal:  Dokl Biol Sci       Date:  2005 May-Jun

Review 7.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

8.  Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and Toll-like receptor activation.

Authors:  Bernt Christian Hellerud; Jørgen Stenvik; Terje Espevik; John D Lambris; Tom Eirik Mollnes; Petter Brandtzaeg
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

9.  CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

Authors:  Erin G Reed-Geaghan; Julie C Savage; Amy G Hise; Gary E Landreth
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

Review 10.  Toll-like receptors and immune response in allergic disease.

Authors:  Sophie C Gangloff; Moncef Guenounou
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.